Clearline Capital Boosts Stake in Globus Medical

Institutional investor increases holding in medical device company by over 340%

Mar. 15, 2026 at 9:50am

Got story updates? Submit your updates here. ›

Clearline Capital LP, an institutional investor, significantly increased its stake in Globus Medical, Inc. (NYSE:GMED) by 342.5% in the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 148,472 shares of the medical device company, worth approximately $8.5 million.

Why it matters

Globus Medical is a leading manufacturer of medical devices for spine and orthopedic applications. The increased investment by Clearline Capital suggests institutional confidence in the company's growth prospects and competitive positioning within the medical device industry.

The details

According to the 13F filing, Clearline Capital purchased an additional 114,917 shares of Globus Medical in the third quarter, bringing its total holding to 148,472 shares. This represents a 342.5% increase in the firm's position. Globus Medical is known for its innovative spine and orthopedic products, including implantable devices and surgical instruments.

  • Clearline Capital increased its stake in Globus Medical during the third quarter of the year.

The players

Clearline Capital LP

An institutional investor that significantly increased its stake in Globus Medical, Inc.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

The substantial increase in Clearline Capital's position in Globus Medical suggests that the institutional investor sees significant growth potential in the medical device company. This development underscores the market's confidence in Globus Medical's innovative product portfolio and its ability to capitalize on trends in the spine and orthopedic device industry.